Casandra
Casandra Test Code QD25122Version 1 (DRAFT)
Performing Lab
17‑Hydroxyprogesterone Neonatal/Infant (17654)
Also known as: 17-Alpha-Hydroxyprogesterone, 17-OHP, OH-Progesterone
Clinical Use
Order TestUse
Quantitative measurement of 17‑hydroxyprogesterone (17‑OHP) in neonatal or infant serum or plasma to evaluate adrenal function; frequently used as a diagnostic marker for congenital adrenal hyperplasia (CAH) in newborns and infants.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Mass Spectrometry
Biomarkers
17‑Hydroxyprogesterone (17‑OHP)
Analyte17‑Hydroxyprogesterone • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
2-5 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.25 mL
Container
Red Top (No Additive); Plasma acceptable: EDTA (lavender‑top), EDTA royal blue‑top, sodium heparin (green‑top), lithium heparin (green‑top)
Causes for Rejection
Serum separator tube (SST)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 Hours |
| Refrigerated | 7 Days |
| Frozen | 2 Years |